Praesidia Biotherapeutics Private Limited - Company Profile

It is a pharma foreign private limited company based in Bangalore North, Karnataka, India, established in 2022.
2022 Bangalore North, Karnataka, India Under Liquidation
Last Updated:
Access Report
About Praesidia Biotherapeutics Private Limited

Praesidia Biotherapeutics Private Limited, a under liquidation foreign private limited company, was established on 14 January 2022 in Bangalore North, Karnataka, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U73100KA2022FTC156670. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.27 M.

It upholds a compliant status. Employing 7 professional, Its leadership includes Sohang Chatterjee (Director), Karthika Nair (Whole-Time Director), Ashish Koppa (Additional Director). Its latest AGM occurred on 23 July 2025, with the balance sheet filed on 31 March 2025. It is based at B-1903, Karle Zenith Residences, 100Ft Kempapura Main Road, Hebbal, Bangalore North, Karnataka, 560045.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2022FTC156670

  • Registration Number

    156670

  • Incorporation Date

    14 January 2022

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.27 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Under Liquidation

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.27 M
  • Company Age 4 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Praesidia Biotherapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Praesidia Biotherapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Praesidia Biotherapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Sohang Chatterjee Director 14 Jan 2022 Current
Karthika Nair Whole-Time Director 14 Jan 2022 Current
Ashish Koppa Additional Director 27 Sep 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Praesidia Biotherapeutics.

Enhance accessibility to Praesidia Biotherapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Praesidia Biotherapeutics revenue growth over time
Praesidia Biotherapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Praesidia Biotherapeutics?

Unlock access to Praesidia Biotherapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Praesidia Biotherapeutics?

Unlock and access historical data on people associated with Praesidia Biotherapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Praesidia Biotherapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Praesidia Biotherapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Praesidia Biotherapeutics
Recent Activity within the Organization
  • Director Appointment

    Progress on Ashish Koppa was appointed as a Additional Director was appointed as a Additional Director on 27 Sep 2025 & has been associated with this company since 5 months 26 days . was documented.

  • Annual General Meeting

    Praesidia Biotherapeutics Private Limited last Annual general meeting of members was held on 23 Jul 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Praesidia Biotherapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    Progress on Sohang Chatterjee was appointed as a Director was appointed as a Director on 14 Jan 2022 & has been associated with this company since 4 years 2 months . was documented.

  • Director Appointment

    The activity Karthika Nair was appointed as a Whole-time director was appointed as a Whole-time director on 14 Jan 2022 & has been associated with this company since 4 years 2 months . was completed.

  • Company Incorporation

    Praesidia Biotherapeutics Private Limited was registered on 14 Jan 2022 with Roc Bangalore & aged 4 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Praesidia Biotherapeutics Private Limited?

The CIN of Praesidia Biotherapeutics Private Limited is U73100KA2022FTC156670.

Where is Praesidia Biotherapeutics Private Limited headquartered?

Praesidia Biotherapeutics Private Limited is headquartered at B-1903, Karle Zenith Residences, 100Ft Kempapura Main Road, Hebbal, Bangalore North, Karnataka, 560045.

When was Praesidia Biotherapeutics Private Limited incorporated?

Praesidia Biotherapeutics Private Limited was incorporated on 14 January 2022.

Who are the current directors of Praesidia Biotherapeutics Private Limited?

The current directors of Praesidia Biotherapeutics Private Limited are

What is the primary industry of Praesidia Biotherapeutics Private Limited?

The primary industry of Praesidia Biotherapeutics Private Limited is Pharma.

Is Praesidia Biotherapeutics Private Limited a listed company?

Praesidia Biotherapeutics Private Limited is unlisted.

What is the capital structure of Praesidia Biotherapeutics Private Limited?

The authorized capital of Praesidia Biotherapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.27 M.

What is the compliance status of Praesidia Biotherapeutics Private Limited?

The compliance status of Praesidia Biotherapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available